The post NICE issues draft ‘no’ on first quadruplet combination for England and Wales appeared first on Myeloma UK.
Recent Content
- Toward functional cure in relapsed/refractory multiple myeloma: long-term outcomes from CARTITUDE-1 study cement the role of CAR-T cells
- 1st trial participant receives Alpha DaRT radiation therapy for glioblastoma
- (no title)
- New targeted cancer therapy IDE034 heading to Phase 1 clinical trial
- (no title)
- Tecvayli-Darzalex Faspro combo up for approval in 2 nations for treating RRMM
- In vivo CAR-T exhibits activity in advanced multiple myeloma
- FDA backs faster development of new therapy for hard-to-treat AML
- The efficacy and safety of anti-CD38 monoclonal antibodies in transplant-ineligible newly diagnosed multiple myeloma: A systematic review and meta-analysis of randomized controlled trials
- Predictive values of baseline 18F-FDG PET/CT for toxicities and outcomes in patients with relapsed or refractory multiple myeloma following BCMA CAR T-cell therapy